Application no. and date | 01918812.7 (espacenet) (Federated) (European Patent Register), 20010316 | Patent/reg. no. and date | DK/EP 1265911, 20080521 | Publication date | 20021218 | Priority no. and date | US 526855, 20000317 | EP pub. no. and date |
EP 1265911 20021218 | Effective date | | Applicant/owner | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, The National Institute of Health,
Office of Technology Transfer,
6011 Executive Boulevard,
Suite 325
Rockville, MD 20852, US | Applicant ref. no. | P80828423DK00E | Inventor | BLYE, Richard, P., 7352 Mink Hollow Road
Highland, MD 20777, US, KIM, Hyun, K., 6308 Marywood Road
Bethesda, MD 20817, US, RAO, Pemmaraju, N., 4307 North Westberry Drive
San Antonio, TX 78228, US, CESSAC, James, W., 11815 Vance Jackson, 602
San Antonio, TX 78230, US, ACOSTA, Carmie, K., 318 Addax
San Antonio, TX 78213, US, SIMMONS, Anne, Marie, 2032 West Mistletoe
San Antonio, TX 78201, US | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 31/57 (2006.01) , A61K 31/575 (2006.01) , A61P 5/36 (2006.01) , C07J 31/00 (2006.01) , C07J 41/00 (2006.01) , C07J 5/00 (2006.01) , C07J 7/00 (2006.01) , C07J 9/00 (2006.01) | Title | 17-alfa-substitueret-11-beta-substitueret-4-aryl og 21-substitueret 19-norpregnadiendion som antiprogestationelle midler | Int. application no. | US2001008681 | Int. publication no. | WO2001074840 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|